These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31585708)

  • 1. The 2016 American Academy of Ophthalmology Recommendations for Hydroxychloroquine Dosing Give Accurate Advice for All Patients.
    Marmor MF
    Ophthalmol Retina; 2019 Oct; 3(10):807-808. PubMed ID: 31585708
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Marmor et al.: American Academy of Ophthalmology Statement: Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). (Ophthalmology 2016;123:1386-1394).
    Murray JJ; Lee MS
    Ophthalmology; 2017 Mar; 124(3):e28-e29. PubMed ID: 28219513
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.
    Marmor MF; Carr RE; Easterbrook M; Farjo AA; Mieler WF;
    Ophthalmology; 2002 Jul; 109(7):1377-82. PubMed ID: 12093666
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxychloroquine: do we all see eye to eye? A single-site analysis of hydroxychloroquine dosing compared with the 2016 Revision of the American Academy of Ophthalmology guidelines.
    Sandhu VK; Goel N; Duro T
    Lupus; 2019 Mar; 28(3):438-439. PubMed ID: 30712492
    [No Abstract]   [Full Text] [Related]  

  • 5. The 2016 American Academy of Ophthalmology Hydroxychloroquine Dosing Guidelines For Short, Obese Patients.
    Browning DJ; Easterbrook M; Lee C
    Ophthalmol Retina; 2019 Oct; 3(10):809-813. PubMed ID: 31400965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIMING FOR THE BULL'S EYE: The Cost-Utility of Screening for Hydroxychloroquine Retinopathy.
    McClellan AJ; Chang JS; Smiddy WE
    Retina; 2016 Oct; 36(10):1958-63. PubMed ID: 27465574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy.
    Marmor MF
    Arthritis Rheum; 2003 Jun; 48(6):1764. PubMed ID: 12794848
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine Prescription Practices after 2016 American Academy of Ophthalmology Recommendations.
    Chen RI; Chen AX; Greenlee TE; Conti TF; Deal C; Singh RP
    Ophthalmology; 2021 Jul; 128(7):1112-1114. PubMed ID: 33741377
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Lyons JS
    Am J Ophthalmol; 2013 Aug; 156(2):410. PubMed ID: 23870365
    [No Abstract]   [Full Text] [Related]  

  • 11. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an Electronic Decision Support Tool to Improve Ophthalmic Safety in Hydroxychloroquine Prescribing Practices.
    Chen RI; Kuo BL; Kalur A; Muste JC; Deal C; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2022 Jun; 53(6):310-316. PubMed ID: 35724373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.
    Jorge AM; Melles RB; Zhang Y; Lu N; Rai SK; Young LH; Costenbader KH; Ramsey-Goldman R; Lim SS; Esdaile JM; Clarke AE; Urowitz MB; Askanase A; Aranow C; Petri M; Choi H
    Arthritis Res Ther; 2018 Jul; 20(1):133. PubMed ID: 29976231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine screening practice patterns within a large multispecialty ophthalmic practice.
    Au A; Parikh V; Modi YS; Ehlers JP; Schachat AP; Singh RP
    Am J Ophthalmol; 2015 Sep; 160(3):561-568.e2. PubMed ID: 26116260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missing the bull's eye.
    Gilbert ME; Savino PJ
    Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine retinopathy after short-term therapy.
    Phillips BN; Chun DW
    Retin Cases Brief Rep; 2014; 8(1):67-9. PubMed ID: 25372212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists.
    Shulman S; Wollman J; Brikman S; Padova H; Elkayam O; Paran D
    Lupus; 2017 Mar; 26(3):277-281. PubMed ID: 27440459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is new in recommendations on ophthalmological screening in patients treated with chloroquine and hydroxychloroquine? Update and literature review.
    Wiacek MP; Bobrowska-Snarska D; Lubiński W; Brzosko M; Modrzejewska M
    Niger J Clin Pract; 2017 Aug; 20(8):919-923. PubMed ID: 28891533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
    Marmor MF; Chien FY; Johnson MW
    JAMA Ophthalmol; 2013 Apr; 131(4):476-80. PubMed ID: 23710501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.